An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
2021 · Nature Communications · 361 citations
https://doi.org/10.1038/s41467-021-22465-w
U
Ulrika Segersten
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
3.0K
Citations
26
h-index
39
i10-index
Ulrika Segersten is an academic researcher from Uppsala University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Epigenetics and DNA Methylation. The author has an h-index of 26, co-authored 77 publications.
Papers by this author
worksAn immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
2023 · EBioMedicine · 72 citations
https://doi.org/10.1016/j.ebiom.2023.104452
Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
2014 · PLoS ONE · 64 citations
https://doi.org/10.1371/journal.pone.0096849
Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
2020 · Scientific Reports · 62 citations
https://doi.org/10.1038/s41598-019-55013-0
The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
2014 · British Journal of Cancer · 57 citations
https://doi.org/10.1038/bjc.2014.427
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
2012 · British Journal of Cancer · 38 citations
https://doi.org/10.1038/bjc.2012.412
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat